Summary
- US Supreme Court supports pharmaceutical companies in challenge to lawsuit alleging terrorism funding activities
- Court threw out lower court ruling, asking for further consideration
- Companies accused of providing corrupt payments to militia group in Iraq to obtain medical supply contracts
- Lawsuit seeks unspecified damages under the Anti-Terrorism Act